Matthew Manzo
Family Medicine · Pinehurst, NCNPI 1376591636
Payments from drug & device makers
Across 193 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Lilly USA, LLC$462
- Novo Nordisk$300
- Amgen$195
- Sanofi-aventis U.S. LLC$192
- AbbVie$187
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,481100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $1,036 |
| Lilly USA, LLC | 23 | $462 |
| Novo Nordisk | 17 | $300 |
| Amgen | 15 | $195 |
| Sanofi-aventis U.S. LLC | 12 | $192 |
| AbbVie | 7 | $187 |
| Exact Sciences | 9 | $172 |
| Boehringer Ingelheim | 7 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $99 |
| GSK | 7 | $91 |
| ANI Pharmaceuticals, Inc. | 3 | $75 |
| Pfizer | 4 | $64 |
| Bayer | 4 | $63 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Edwards Lifesciences | 2 | $48 |
| Corcept Therapeutics | 3 | $48 |
| Novartis | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 4 | $26 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,490 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 207 | $234,948 |
| OzempicSemaglutide | 149 | $181,381 |
| JardianceEmpagliflozin | 118 | $143,913 |
| EliquisApixaban | 110 | $91,928 |
| FarxigaDapagliflozin Propanediol | 100 | $70,176 |
| LinzessLinaclotide | 81 | $69,283 |
| TrulicityDulaglutide | 64 | $68,795 |
| JanuviaSitagliptin Phosphate | 50 | $47,726 |
| OxycontinOxycodone Hcl | 29 | $34,538 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $34,163 |
| Repatha SureclickEvolocumab | 20 | $34,129 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $32,625 |
| VraylarCariprazine Hcl | 22 | $31,309 |
| JanumetSitagliptin Phos/Metformin Hcl | 46 | $30,271 |
| XareltoRivaroxaban | 26 | $26,559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $462 | $303,743271 claims |
| Novo NordiskOzempic | $300 | $181,381149 claims |
| Boehringer IngelheimJardiance | $107 | $143,913118 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,036 | $102,022172 claims |
| AbbVieLinzess, Vraylar | $187 | $100,592103 claims |
| PfizerEliquis, Premarin | $64 | $97,177124 claims |
| GSKTrelegy Ellipta, Shingrix, Breo Ellipta, Incruse Ellipta | $91 | $77,445213 claims |
| Johnson & JohnsonXarelto | $28 | $26,55926 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $19 | $21,17427 claims |
| Astellas Pharma US IncMyrbetriq | $16 | $19,92439 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $99 | $12,65626 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Pinehurst
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.